Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Karina Nakajima, PhD
Pfizer Inc., New York, NY, USA
Poster(s):
(T 83) Real-World Longitudinal Outcomes of Acute Rimegepant in a Tertiary Migraine Population
(T 102) Interim analysis of CORRELATE-UK: A prospective real-world study of the patient-reported consistency of response to rimegepant in acute treatment of migraine